GL1X · GenesisL1 explorer

Research workbench

The structure and function of an arabinan-specific alpha-1,2- arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases

Analyse The structure and function of an arabinan-specific alpha-1,2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3QEF
Type
protein
Length
593 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-XYLOSIDASE/ALPHA-L-arabinfuranosidase, GLY43N
EC
3.2.1.-
UniProt
B3PD60
Ligands
AHR, CA
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 2% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-XYLOSIDASE/ALPHA-L-arabinfuranosidase, GLY43N (EC 3.2.1.-)protein2962% helix, 49% strandB3PD60
BBeta-XYLOSIDASE/ALPHA-L-arabinfuranosidase, GLY43N (EC 3.2.1.-)protein2972% helix, 49% strandB3PD60

Ligands and binding sites

  • AHR · alpha-L-arabinofuranose · sugar · 7 copies · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12560.740.8852empty
24190.720.8369AHR, EDO
32690.540.7622empty
42590.540.7622empty
5520.310.7722empty

Interfaces

1 interface between chains.

  • A–B · 981 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 3QEF · The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.